Sectors
University Ventures, CDC Group and Savannah Fund have injected $12m into Unicaf to help it establish learning centres across several African cities.
The biotherapeutics developer, a UCSF spinout, raised funds from backers like cancer immunotherapy developer Kite Pharma, a UCLA spinout.
The spinout has raised additional funding after announcing earlier this month that it had become the first company to sequence multiple human genomes using portable technology.
Sussex spinout Enterprise Therapeutics, a developer of treatments for respiratory diseases, has secured capital from return investor Imperial Innovations.
The taxi and limousine services provider joined corporates Recruit and Kyoto Bank in the latest funding round for the Dentsu-backed robo-adviser.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
